| Mar 27, 2024 |
Mar 28, 2024 |
Gossamer Bio, Inc.
|
EVP, Tech Ops and Admin |
Sell |
50.0
|
-6,430
|
-0.97%
|
✗
|
$7.4K |
| Mar 20, 2023 |
Mar 22, 2023 |
Gossamer Bio, Inc.
|
EVP, Tech Ops and Admin |
Buy |
83.8
|
+18,500
|
2.99%
|
✗
|
$22.1K |
| Jul 15, 2022 |
Jul 15, 2022 |
Gossamer Bio, Inc.
|
EVP, Tech Ops and Admin |
Buy |
78.8
|
+6,934
|
1.14%
|
✗
|
$50K |
| Mar 23, 2022 |
Mar 24, 2022 |
Gossamer Bio, Inc.
|
EVP, Tech Ops and Admin |
Sell |
42.5
|
-10,722
|
-1.73%
|
✗
|
$95.6K |
| Dec 21, 2021 |
Dec 23, 2021 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Sell |
90.0
|
+10,152
|
290.06%
|
✓
|
$2.9K |
| Sep 21, 2021 |
Sep 23, 2021 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Sell |
33.8
|
-300
|
-7.89%
|
✓
|
$3.7K |
| Jun 21, 2021 |
Jun 22, 2021 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Sell |
37.5
|
-300
|
-7.32%
|
✓
|
$4.6K |
| Apr 15, 2021 |
Apr 16, 2021 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Sell |
37.5
|
-300
|
-6.82%
|
✓
|
$5.3K |
| Mar 23, 2021 |
Mar 25, 2021 |
Gossamer Bio, Inc.
|
EVP & General Counsel |
Sell |
45.0
|
-5,490
|
-0.88%
|
✗
|
$52.1K |
| Oct 14, 2020 |
Oct 14, 2020 |
Gossamer Bio, Inc.
|
EVP & General Counsel |
Buy |
61.3
|
+2,500
|
0.44%
|
✗
|
$23.8K |
| Sep 27, 2019 |
Sep 27, 2019 |
Gossamer Bio, Inc.
|
EVP & General Counsel |
Buy |
56.3
|
+1,000
|
0.19%
|
✗
|
$16.7K |
| May 15, 2019 |
May 16, 2019 |
HERON THERAPEUTICS, INC. /DE/
|
Director |
Buy |
91.3
|
+1,400
|
100.00%
|
✗
|
$25.3K |
| Feb 12, 2019 |
Feb 12, 2019 |
Gossamer Bio, Inc.
|
EVP & General Counsel |
Buy |
61.3
|
+1,550
|
0.30%
|
✗
|
$24.8K |